The depsychiatrisation of mental illness

Journal of Public Mental Health

Volumn 4, Issue 3, 2005, Pages 8-13

  Dumit, Joseph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Algorithm; Diagnosis; Marketing; Pharmaceutical industry; Psychotropic drugs

Indexed keywords

EID: 41749091722     PISSN: 17465729     EISSN: 20428731     Source Type: Journal    
DOI: 10.1108/17465729200500019     Document Type: Review

References (26)

1. Abboud L (2004) Should family doctors treat serious mental illness? Psychiatrists voice concerns as more general physicians prescribe antipsychotic drugs. Wall Street Journal, 24 March.
2. Abboud L (2005) Mental illness said to affect one-quarter of Americans; NIH report cites problems with adequate treatment; a debate over definitions. Wall Street Journal, 7 June.
3. Aikin KJ (2003) Direct-to-consumer advertising of prescription drugs: physician survey preliminary results. Division of Drug Marketing, Advertising and Communications, Center for Drug Evaluation and Research, US Food and Drug Administration. http://www.fda.gov/cder/ddmac/globalsummit2003/
4. Canguilhem G (1989) The normal and the pathological. Trans. CR Fawcett. Originally published in French 1966. New York: Zone Books.
5. Casel.org (2005) The Children's Mental Health Act, and the Strategic Plan for Building a Comprehensive Children's Mental Health System in Illinois. http://www.casel.org/projects_products/CMHA.php, http://www.casel.org/home/index.php (accessed 16 August 2005).
6. Castel R (1991) From dangerousness to risk. In: Burchell G, Gordon C, Miller P (eds) The Foucault effect: studies in governmentality. Chicago: University of Chicago Press.
7. Cox TP (2002) Forging alliances. Pharmaceutical Executive 8.
8. Derbyshire D (2002) Cholesterol drug ‘can save 10,000 lives’. Daily Telegraph, 5 July.
9. Diamond F (2000) Nurse practitioners inch onto the field; Thanks, in part, to new federal guidelines, this ‘invisible player’ is starting to be noticed; Can NPs do more than fill niches? Managed Care 9 (8).
10. Dumit J (forthcoming) Illnesses you have to fight to get: facts as forces in uncertain, emergent illnesses. Social Science & Medicine.
11. Dumit J (2003) Managing mind and mood through facts and pharmaceuticals. Emergent forms of life: towards an anthropology of life sciences. First Blankensee Colloquium. Wissenschaftskolleg, Berlin. 11-13 December.
12. Edlen-Nezin L (2003) Breaking through denial. Pharmaceutical Executive 23.
13. Elliott S (2004) With its Viagra under attack by new rivals, Pfizer chooses a new agency for ads in the United States. New York Times, 30 June.
14. Greco M (1993) Psychosomatic subjects and the ‘duty to be well’: personal agency within medical rationality. Economy and Society 22 (3) 357-372.
15. Greenslit N (forthcoming) DEP®ESSION and CONSUM?TION: psychopharmaceuticals, branding and new identity practices. Culture, Medicine & Psychiatry.
16. Healy D (2002). The creation of psychopharmacology. Cambridge, MA: Harvard University Press.
17. Jones A (2004) Smoke and mirrors: the Texas medication algorithm project. Law Project for Psychiatric Rights.
18. http://psychrights.org/Drugs/AllenJonesTMAPJanuary20.pdf (accessed Aug 16, 2005).
19. Lakoff A (2004) The anxieties of globalisation: antidepressant sales and economic crisis in Argentina. Social Studies of Science 34 247-269.
20. Landers P (2002) Waiting for Prozac: drug firms push Japan to change view of depression; Once-taboo illness is dubbed ‘The soul catching a cold’; Big market for new pills; A tv star saved from suicide. Wall Street Journal (Eastern edition), 9 October.
21. Lee S (2004) New directions in medical education. Pharmaceutical Education 1 50.
22. Rampton S, Stauber J (2001) Trust us, we're experts! how industry manipulates science and gambles with your future. New York: Jeremy P Tarcher/Putnam.
23. Robinson R (2004). Illinois Children's Mental Health Plan gives legislators headache. Illinois Leader, 17 August http://www.illinoisleader.com/news/newsview.asp?c=18658 (accessed 16 August 2005).
24. San Martin N (2001) State spending more on mental illness drugs; Health officials try to deal with rise. Dallas Morning News, 12 February.
25. Shalo S (2004) Built for speed. Pharmaceutical Executive 24 (2) 40.
26. Winslow (2004) Blood feud: for Bristol-Myers, challenging Pfizer was a big mistake; In rare head-to-head study, Lipitor beats Pravachol at reducing heart risk; A new push on cholesterol. Wall Street Journal, 9 March.